A tobacco extract containing alkaloids induces distinct effects compared to pure nicotine on dopamine release in the rat

Neuroscience Letters

Volumn 544, Issue , 2013, Pages 85-88

  Khalki, Hanane ^a   Navailles, Sylvia ^b,c   Piron, Camille L ^b,c   De Deurwaerdère, Philippe ^b,c  

^a FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

Author keywords

Dopamine release; Intracerebral microdialysis; Nicotine; Nucleus accumbens; Striatum; Tobacco alkaloid extract

Indexed keywords

ALKALOID; DOPAMINE; NICOTINE;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; IN VIVO STUDY; MICRODIALYSIS; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SMOKING; TOBACCO;

ALKALOIDS; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; MALE; NICOTINE; NUCLEUS ACCUMBENS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TOBACCO;

EID: 84878410846     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.047     Document Type: Article

References (28)

1. Boye S.M., Grant R.J., Clarke P.B.S. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and d-amphetamine in rats. Neuropharmacology 2001, 40:792-805.
2. Clemens K.J., Caillé S., Stinus L., Cador M. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int. J. Neuropsychopharmacol. 2009, 12:1355-1366.
3. Crooks P.A., Dwoskin L.P. Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine. Drug Metab. Dispos. 1995, 23:1175-1177.
4. Crooks P.A., Dwoskin L.P. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem. Pharmacol. 1997, 54:743-753.
5. Crooks P.A., Min L., Dwoskin L.P. Metabolites of nicotine in rat brain after peripheral nicotine administration cotinine, nornicotine, and norcotinine. Drug Metab. Dispos. 1997, 25:47-54.
6. De Deurwaerdère P., Navailles S., Berg K.A., Clarke W.P., Spampinato U. Constitutive activity of the serotonin 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci. 2004, 24:3235-3241.
7. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5274-5278.
8. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 1995, 38:95-137.
9. Dunnett S.B., Robbins T.W. The functional role of mesotelencephalic dopamine systems. Biol. Rev. Camb. Philos. Soc. 1992, 67:491-518.
10. Exley R., McIntosh J.M., Marks M.J., Maskos U., Cragg S.J. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J. Neurosci. 2012, 32:2352-2356.
11. Fenster C.P., Rains M., Noerager B., Quick M.W., Lester R. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J. Neurosci. 1997, 17:5747-5759.
12. Ghosheh O., Dwoskin L.P., Li W.-K., Crooks P.A. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [29-14C] nicotine. Drug Metab. Dispos. 1999, 27:1448-1455.
13. Guillem K., Vouillac C., Azar M.R., Parsons L.H., Koob G.F., Cador M., Stinus L. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J. Neurosci. 2005, 25:8593-8600.
14. Harvey M.D., Yasar S., Heishman S.J., Panlilio L.V., Henningfield J.E., Goldberg S.R. Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl.) 2004, 175:134-142.
15. Janhunen S., Linnervuo A., Svensk M., Ahtee L. Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats. Pharmacol. Biochem. Behav. 2005, 82:758-765.
16. Khalki H., Khalki L., Aboufatima R., Ouachrif A., Mountassir M., Benharref A., Chait A. Prenatal exposure to tobacco extract containing nicotinic alkaloids produces morphological and behavioral changes in newborn rats. Pharmacol. Biochem. Behav. 2012, 101:342-347.
17. Kyerematen G.A., Morgan M.L., Chattopadhyay B., deBethizy J.D., Vesell E.S. Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification of two metabolites that are longer lived than cotinine. Clin. Pharmacol. Ther. 1990, 48:641-651.
18. Lapin E.P., Howard S.M., Henry S., Lajtha A. Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur. J. Pharmacol. 1989, 160:53-59.
19. Liu Z.H., Jin W.Q. Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats. Neuroreport 2004, 15:1479-1481.
20. Lucas G., Spampinato U. Role of striatal Serotonin2A and Serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J. Neurochem. 2001, 74:693-701.
21. Marks M.J., Grady S.R., Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 1993, 266:1268-1276.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic press, N.Y.
23. Pietilä K., Ahtee L. Chronic nicotine administration in the drinking water affects the striatal dopamine in mice. Pharmacol. Biochem. Behav. 2000, 66:95-103.
24. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382:255-257.
25. Rose J.E., Corrigall W.A. Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl.) 1997, 130:28-40.
26. Shannon G.M., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J., Caggiula R.A., Craig C.R., Collins A.C., Damaj M.I., Donny E.C. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl.) 2007, 190:269-319.
27. Touiki K., Rat P., Molimard R., Chait A., De Beaurepaire R. Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. Neuropharmacol. Neurotoxicol. 2007, 18:925-929.
28. Vezina P., Blanc G., Glowinski J., Tassin J.-P. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J. Pharmacol. Exp. Ther. 1992, 261:484-490.